Literature DB >> 18532929

The 2007 WHO classification of tumors of the nervous system: controversies in surgical neuropathology.

Bernd W Scheithauer1, Greg N Fuller, Scott R VandenBerg.   

Abstract

Controversy surrounds the recent 2007 WHO Classification of Tumours of the Nervous System. A number of nosologic issues remain to be resolved, some a reflection of conceptual disagreement, others the result of inadequate data to permit their definitive resolution. Among these and discussed herein are (i) the nosologic place of highly anaplastic oligoastrocytic tumors, (ii) the forms and significance of microvascular changes in high-grade gliomas, (iii) the makeup of the glioneuronal tumors category, (iv) the subclassification of pineal parenchymal tumors of intermediate type, and (v) the classification of principle forms of mesenchymal neoplasms, specifically hemangiopericytoma and solitary fibrous tumor. These issues and others are the substance of this and an upcoming companion article.

Entities:  

Mesh:

Year:  2008        PMID: 18532929     DOI: 10.1111/j.1750-3639.2008.00179.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  22 in total

1.  HMGA1 expression in human gliomas and its correlation with tumor proliferation, invasion and angiogenesis.

Authors:  Bo Pang; Haitao Fan; Ian Y Zhang; Bin Liu; Bin Feng; Lei Meng; Rui Zhang; Sam Sadeghi; Hua Guo; Qi Pang
Journal:  J Neurooncol       Date:  2011-10-08       Impact factor: 4.130

Review 2.  Biology, genetics and imaging of glial cell tumours.

Authors:  C Walker; A Baborie; D Crooks; S Wilkins; M D Jenkinson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

3.  Assessing the efficacy of repeat resections in recurrent glioblastoma: a systematic review.

Authors:  David Botros; Hayden Dux; Carrie Price; Adham M Khalafallah; Debraj Mukherjee
Journal:  Neurosurg Rev       Date:  2020-06-13       Impact factor: 3.042

4.  Gene expression in oligodendroglial tumors.

Authors:  Elisabeth J Shaw; Brian Haylock; David Husband; Daniel du Plessis; D Ross Sibson; Peter C Warnke; Carol Walker
Journal:  Cell Oncol (Dordr)       Date:  2011-05-31       Impact factor: 6.730

5.  Metformin influences progression in diabetic glioblastoma patients.

Authors:  Sebastian Adeberg; Denise Bernhardt; Semi Ben Harrabi; Tilman Bostel; Angela Mohr; Christian Koelsche; Christian Diehl; Stefan Rieken; Juergen Debus
Journal:  Strahlenther Onkol       Date:  2015-09-02       Impact factor: 3.621

6.  Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping.

Authors:  Yinyan Wang; Tianyi Qian; Gan You; Xiaoxia Peng; Clark Chen; Yongping You; Kun Yao; Chenxing Wu; Jun Ma; Zhiyi Sha; Sonya Wang; Tao Jiang
Journal:  Neuro Oncol       Date:  2014-07-16       Impact factor: 12.300

7.  Methylation Status of the O6-Methylguanine-Deoxyribonucleic Acid Methyltransferase Gene Promoter in World Health Organization Grade III Gliomas.

Authors:  Seung-Heon Yang; Yong Hwy Kim; Jin Wook Kim; Chul-Kee Park; Sung-Hye Park; Hee-Won Jung
Journal:  J Korean Neurosurg Soc       Date:  2009-10-31

8.  Radiotherapy plus concomitant temozolomide in primary gliosarcoma.

Authors:  Sebastian Adeberg; Denise Bernhardt; Semi Ben Harrabi; Christian Diehl; Christian Koelsche; Stefan Rieken; Andreas Unterberg; Andreas von Deimling; Juergen Debus
Journal:  J Neurooncol       Date:  2016-03-30       Impact factor: 4.130

9.  Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy.

Authors:  Chul-Kee Park; Se-Hoon Lee; Jung Ho Han; Chae-Yong Kim; Dong-Wan Kim; Sun Ha Paek; Dong Gyu Kim; Dae Seog Heo; Il Han Kim; Hee-Won Jung
Journal:  BMC Cancer       Date:  2009-12-18       Impact factor: 4.430

10.  CRX is a diagnostic marker of retinal and pineal lineage tumors.

Authors:  Sandro Santagata; Cecile L Maire; Ahmed Idbaih; Lars Geffers; Mick Correll; Kristina Holton; John Quackenbush; Keith L Ligon
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.